Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
Autor: | Jimmy Yee, Shawn Kelly, Vishesh Kumar, Amornpol Anuwatworn, Amol Raizada, Maria Stys, Adam Stys |
---|---|
Rok vydání: | 2017 |
Předmět: |
medicine.medical_specialty
medicine.medical_treatment Case Report 030204 cardiovascular system & hematology Transesophageal echocardiogram Mechanical valve Dabigatran 03 medical and health sciences Fatal Outcome 0302 clinical medicine Rivaroxaban Internal medicine Humans Medicine Thrombolytic Therapy 030212 general & internal medicine Heart Valve Prosthesis Implantation medicine.diagnostic_test business.industry Cardiogenic shock Mechanical Aortic Valve Thrombosis Aortic Valve Stenosis Off-Label Use General Medicine Thrombolysis Middle Aged medicine.disease Echocardiography Doppler Color Surgery Treatment Outcome Aortic Valve Heart Valve Prosthesis Cardiology Female business Echocardiography Transesophageal Factor Xa Inhibitors medicine.drug |
Zdroj: | Methodist DeBakey Cardiovascular Journal. 13:73 |
ISSN: | 1947-6108 1947-6094 |
DOI: | 10.14797/mdcj-13-2-73 |
Popis: | This is a case of a 54-year-old female with a history of mechanical aortic valve replacement who presented in cardiogenic shock. Her primary care provider started her on rivaroxaban for anticoagulation therapy. An urgent transesophageal echocardiogram revealed a significant gradient and thrombosis on one leaflet of the valve that was immobile. Given that she was not a surgical candidate, she underwent thrombolysis. However, she later died due to complications from the thrombotic valve. The utility of target-specific oral anticoagulants has yet to be established in clinical practice. |
Databáze: | OpenAIRE |
Externí odkaz: |